Login / Signup

Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.

Pierre DecazesSamy AmmariYounes BelkouchiLéo MottayLittisha LawranceAntoine de PréviaHugues TalbotSiham FarhanePaul-Henry CournèdeAurélien MarabelleFlorian GuisierDavid PlanchardTony IbrahimCaroline RobertFabrice BarlesiPierre VeraNathalie Lassau
Published in: Journal for immunotherapy of cancer (2023)
3D measured low SFM and MBM are significant prognosis factors of NSCLC treated by immune checkpoint inhibitors and can be combined to improve the prognostic value.
Keyphrases